To investigate the feasibility of histogram analysis with computed tomography angiography (CTA) in distinguishing between soft tissue sarcomas and benign soft tissue tumors. Fourty nine patients (23 men, mean age = 44.3 years, age range = 25-64) with pathologically-confirmed soft tissue sarcoma (n = 24) or benign soft tissue tumors (n = 25) in the lower extremities undergoing CTA for tumor evaluation were retrospectively analyzed. Two radiologists separately performed histogram analyses of CT density with CTA images by drawing a region of interest (ROI). The 10th (P10), 25th (P25), 50th (P50), 75th (P75), 90th percentiles (P90), mean, and standard deviations (SD) of measured tumor density were obtained along with measurements of the absolute value of kurtosis (AVK), absolute value of skewness (AVS), and inhomogeneity for each tumor. Intra-class correlation coefficients (ICC) were calculated to determine inter-and intra-reader variability in parameter measurements. The Mann-Whitney U test was used to compare histogram parameters between soft tissue sarcomas and benign soft tissue tumors. Receiver operator characteristic (ROC) curves were constructed to evaluate the accuracy of tumor discrimination. ICC was greater than 0.7 for AVS, AVK, and inhomogeneity, and >0.9 for mean, SD, and all percentile measures. There was no significant difference in P10, P25, P50, P75, P90, mean, or SD between soft tissue sarcomas and benign tumors (P > .05). AVS, AVK, and inhomogeneity were significantly higher in soft tissue sarcomas (P < .05). Areas under the curve (AUC) were 0.81, 0.83, and 0.84 for AVS, AVK, and inhomogeneity respectively. AUC were below 0.6 for mean, SD, and all percentiles.
Introduction
Computed tomography (CT) is often not the preferred modality for imaging extremity soft tissue tumors due to poor contrast resolution. [1, 2] However, recent studies have found that computed tomography texture analysis (CTTA) can identify and quantify tumor spatial heterogeneity. [3] [4] [5] [6] [7] Histogram analysis of CT density, one of the most widely used CTTA methods, has been reported to distinguish between benign and malignant lesions [8] [9] [10] based on differences in heterogeneity. Compared with non-contrast CT, contrast enhanced CT may be more useful for histogram analysis of density, as tissue CT attenuation and spatial heterogeneity are increased with the latter. [11] [12] [13] Computed tomography angiography (CTA) is frequently used for evaluating soft tissue masses in the lower extremity, as it can provide information regarding blood supply and vascular invasion. [14, 15] CTA is often a preoperative requirement for large soft tissue tumors to assess regional vascular invasion. [16, 17] In addition, CTA can determine the number of feeding arteries, which is valuable in distinguishing between benign and malignant soft tissue tumors, the latter which tend to have more feeding arteries. [18] As with conventional contrast-enhanced CT, CTA is more suitable than non-contrast CT for histogram analysis. [19] Soft tissue sarcomas in the lower extremity generally have an inhomogeneous density distribution due to complex pathological changes including bleeding, necrosis, and calcification. [20, 21] In distinction, benign soft tissue tumors typically have a simple structure and more homogeneous density distributions. [22] We here hypothesize: histogram analysis with CTA can identify and quantify tumor heterogeneity and that benign soft tissue tumors and soft tissue sarcomas differ in spatial heterogeneity. The purpose of the study is therefore to investigate the feasibility of histogram analysis with CTA in distinguishing between soft tissue sarcomas and benign soft tissue tumors.
Methods

Patients
This retrospective study was approved by the Institutional Review Broad of our university. Inform consent was obtained from each patient before study. Inclusion criteria were patients with a pathologically-confirmed benign lower extremity soft tissue tumor or soft tissue sarcoma; patients with a lower extremity CTA examination performed for tumor evaluation. Exclusion criteria were tumors containing predominantly fat, such as lipomas and seriously calcified tumor with calcified scope >30%. Sixty patients from March 2013 to October 2018 were enrolled in this study. Exclusion of patients was as follows: tumors with fat (n = 7); seriously calcified tumors (n = 4). Thus, a total of 49 patients with soft tissue tumors were analyzed.
CTA examinations
All CTA examinations were performed on a 128-row CT scanner (Discovery HD 750, GE Healthcare, Milwaukee, WI, USA). The main scan parameters were as follows: tube voltage, 100 kV; tube current, 150 mA; pitch, 0.984:1; thickness, 0.625 mm; field of view, 50 cm. The contrast agent was injected through the antecubital vein by an automatic injector. The flow rate was 3 mL/s. A region of interest (ROI) was drawn at the aortic bifurcation for tracking. Image acquisition automatically began 5.5 seconds after the attenuation in the ROI reached a threshold of 120 Hounsfield units (HU).
Pathology results
The 49 soft tissue tumors were divided into 2 groups according to the 2013 WHO classification of bone and soft tissue tumors: the soft tissue sarcoma group and benign soft tissue tumor group. The pathology types for soft tissue sarcoma group (n = 24) were as follows: synovial sarcoma (n = 4), fibrosarcoma (n = 7), rhabdomyosarcoma (n = 5), leiomyosarcoma (n = 3), epithelioid sarcoma (n = 2), and hemangiosarcoma (n = 3). The pathology types for benign soft tissue tumor group (n = 25) were as follows: fibroma (n = 9), schwannoma (n = 5), hemangioma (n = 7), intramuscular myxoma (n = 2), and tenosynovial giant cell tumor (n = 2).
Data analysis
Two radiologists with 8 and 9 years' experience in orthopedic oncologic imaging separately performed a histogram analysis of CT density by drawing an ROI on CT source images using Firevoxel. The radiologist with 8 years' experience was asked to perform a second analysis for all cases after an interval of 4 weeks. The ROIs were drawn in different areas on the slice where the tumor size was the greatest. Histogram derived parameters were as follows: 10th percentile (P10), 25th percentile (P25), 50th percentile (P25), 75th percentile (P75), 90th percentile (P90), mean, standard and deviation (SD) of measured tumor density as well as skewness, kurtosis, and inhomogeneity. Absolute values were obtained for skewness and kurtosis (AVS and AVK, respectively).
Statistical analysis
All statistical analysis was performed using SPSS 21.0 (SPSS Inc., Chicago, IL, USA). Intra-class correlation coefficients (ICC) were calculated to determine inter-or intra-reader variability in parameter measurements. ICC above 0.7 were considered excellent reproducibility. ICC below 0.4 were considered poor reproducibility. ICC between 0.4 and 0.7 were considered acceptable. Histogram parameters were compared between the 2 groups using a Mann-Whitney U test. The non-paired student's t test was used to compare patient ages between the 2 groups. The chi-square test was used to identify sex differences between the 2 groups. Receiver operator characteristic (ROC) curves were constructed for determining the ability to distinguish benign and malignant tumors. P-values <.05 were considered statistically significant.
Results
Reproducibility of measurement
Inter-reader ICC was >0.7 for AVS, AVK, and inhomogeneity, and >0.9 for P10, P25, P50, P75, P90, mean, and SD (see Table 1 ). Intra-reader ICC was >0.7 for AVS, AVK, and inhomogeneity, and >0.9 for P10, P25, P50, P75, P90, mean, and SD (see Table 1 ).
Comparisons between soft tissue sarcomas and benign soft tissue tumors
There was no significant difference in age or sex (P > .05) between the soft tissue sarcoma (n = 24, mean age = 46.4 years, age range = 28-64, male: female = 11:13) and benign tumor groups (n = 25, mean age = 42.3 years, age range = 25-60, male: female = 12:13).
Benign soft tissue tumors and soft tissue sarcomas did not differ in P10, P25, P50, P75, P90, mean, or SD of density (P > .05, see Table 2 ). AVS, AVK, and inhomogeneity were significantly higher in soft tissue sarcomas versus benign soft tissue tumors (P < .05, see Table 2 ).
The area under the curve (AUC) was below 0.6 for P10, P25, P50, P75, P90, mean, and SD. AUC was 0.81, 0.83, and 0.84 for AVS, AVK, and inhomogeneity, respectively. Table 1 Intra-reader and inter-reader reproducibility for histogram parameters were determined by calculating intra-class correlation coefficients. 
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Discussions
The current study investigated the feasibility of CTA-derived histogram analysis in distinguishing between soft tissue sarcomas from benign soft tissue tumors. The most important findings are as follows: the reproducibility of CTA histogram analyses is excellent; soft tissue sarcoma and benign soft tissue tumors differ in AVS, AVK, and inhomogeneity, but not in mean, SD, or percentile density measurements. Histogram analysis of CT density is one of the most widely used CTTA methods. [23] [24] [25] Compared with basic ROI analysis, more parameters can be obtained with histogram analysis, such as percentiles, skewness, kurtosis, and inhomogeneity. Percentiles provide additional information regarding density distributions. Skewness and kurtosis reflect the extent of deviation from a normal distribution. Skewness, kurtosis, and inhomogeneity have been reported as additional valuable parameters reflecting tumor heterogeneity. [3, 26, 27] Malignant tumors generally enhance more robustly than benign tumors due to greater neovascularity. CT density parameters derived from contrast-enhanced CT were expected to be higher in soft tissue sarcomas than in benign soft tissue tumors. However, no difference in histogram-derived CT density parameters was identified between the 2 groups. The most likely explanation is that the early tumor enhancement achieved with CTA only slightly elevated the overall tumor density. The standard deviation of CT density parameters also did not differ between the 2 groups, and the AUC for both mean and SD were poor (<0.6). Thus, basic analyses of mean/SD were not suitable for distinguishing between soft tissue sarcomas and benign soft tissue tumors.
The percentile values (P10-P90) also did not differ between soft tissue sarcomas and benign tumors. P10 likely represents voxels within areas of liquefied necrosis, as the absolute values were approximately the density of water. Both benign and malignant soft tissue tumors could have liquefied necrosis, reflecting similar P10 values. P90 most likely reflects intravascular enhancement as its absolute value was >100 HU for both groups. As enhanced vessels are present in both benign tumors and soft tissue sarcomas, P90 values also did not differ between the groups. Benign tumors and soft tissue sarcomas also did not differ in P50, which was close to the mean density of the tumor. AUC values were poor (<0.6) for P25 and P75. Thus, CT Median values were provided in the table for the histogram parameters. AVK = absolute value of kurtosis, AVS = absolute value of skewness, P10 = 10th percentile, P25 = 25th percentile, P50 = 50th percentile, P75 = 75th percentile, P90 = 90th percentile, SD = standard deviation. Figure 1 . A 40-year-old man with a large soft tissue mass in the left thigh. Feeding arteries were well-depicted on maximum intensity projection CTA images (A, arrows). The tumor boundaries were not well-depicted on CTA source images (B), but the images clearly demonstrate tumor displacement of the regional arteries (B, arrows). Intra-tumor hemorrhage is seen on the T1-weighted MR images (C, arrows), while necrosis is better visualized on the T2-weighted images (D, arrows). Tumor enhancement was heterogeneous (E). Contrast-enhanced T1-weighted images also showed show multiple areas of necrosis (E, arrows). Kurtosis, skewness, and inhomogeneity derived from the histogram (F) were 0.94, 0.79, and 0.42, respectively. The pathology showed an epithelioid sarcoma (G).
Wu et al. Medicine (2020) 99:2 www.md-journal.com Figure 2 . A 62-year-old man with a mass in the right thigh. The tumor was hyperintense on the T1-weighted MR image (A, arrows), and heterogeneously hyperintense on the T2-weighted image (B, arrows). The enhancement was heterogeneous on the contrast-enhanced T1-weighted image (C, arrows) and the CTA source image (D, arrows). The main arteries were free from tumor, and the feeding artery was well-depicted on reconstructed maximum intensity projection CTA images (E, arrows). Kurtosis, skewness, and inhomogeneity derived from the histogram (F) were -0.68, 0.48, and 0.54, respectively. The pathology showed a leiomyosarcoma (G). CTA = computed tomography angiography. Figure 3 . An 84-year-old man with a right thigh mass. T1 and T2-weighted MR images depicted the tumor (A, B, arrows) . CTA was performed to better delineate tumor involvement of the adjacent femoral artery. The CTA image was superior to MR in confirming the lack of arterial invasion (C, arrows). The tumor feeding artery was also identified on a reconstructed maximum intensity projection CTA image (D, arrows). Kurtosis, skewness, and inhomogeneity derived from the histogram (E) were 0.15, 0.21, and 0.23, respectively. The pathology showed a schwannoma (F). CTA = computed tomography angiography. density percentiles (P10-P90) appear to not be suitable for discrimination of benign and malignant tumors. Despite the inability of CTA-derived mean and percentile values to discriminate between benign and malignant tumors, histogram analysis of CTA data still proved valuable as the parameters of skewness, kurtosis, and inhomogeneity did allow for this differentiation. AUC for AVS, AVK, and inhomogeneity were all >0.8. The measurement reproducibility for these parameters was also excellent (ICC >0.7) for AVS, AVK, and inhomogeneity.
The distribution of CT densities may be normal or nearly normal in benign lesions, but as the current study supports, non-normal distributions are commonly found in malignant tumors. [28] Parameters that reflected the extent of deviation from a normal distribution (including AVK, AVS, and inhomogeneity) were significantly higher in soft tissue sarcomas compared with benign tumors. The most likely explanation for this is the complex structure and greater variety of pathological changes seen with sarcomas including areas of necrosis, hemorrhage, and calcification.
The current study has some limitations. First, the sample size was small, especially for the soft tissue sarcoma group. Soft tissue tumors in the lower extremity are uncommon, and CTA is not typically performed for small lower extremity tumors. Thus only 49 cases met the inclusion criteria over nearly 5 years. Larger multi-center studies are needed to validate the current results. Second, the histogram analyses were performed using CTA, not conventional contrast enhanced CT. Tumor enhancement extent may differ between the 2 tests. However, conventional contrast enhanced CT is seldom utilized for the assessment of soft tissue tumors in the lower extremity due to inadequate soft tissue resolution. Histogram analysis with MRI is an additional area of potential future research, but the current study was focused on CTTA. Third, the benign soft tissue tumor group consisted of several pathologically distinct entities. The sample size for each benign tumor group was too small to support separate statistical analysis, and thus all benign tumors were combined into one group. Optimally, a more direct comparison should be performed in future studies, such as fibrosarcoma versus fibroma.
In conclusion, skewness, kurtosis, and inhomogeneity derived from histogram analysis with CTA could be useful in distinguishing between soft tissue sarcomas and benign soft tissue tumors.
